Mutual of America Capital Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
Mutual of America Capital Management's ANGO Position: Q4 2022 in Review
Mutual of America Capital Management sold out of AngioDynamics (ANGO) in Q4 2022, closing a stake of 7,753 shares — an estimated $159K sold.
Mutual of America Capital Management first reported a position in ANGO in Q3 2016 and held it in 21 quarters. The position peaked at $159K in Q3 2022. 149 funds tracked by Wall St. Rank hold ANGO as of Q4 2022.
- Mutual of America Capital Management reported no remaining AngioDynamics position as of Q4 2022 after selling out during the quarter.
- Mutual of America Capital Management sold 7,753 AngioDynamics shares in Q4 2022, an estimated $159K.
- Mutual of America Capital Management first reported a position in AngioDynamics in Q3 2016 and held it in 21 quarters.
- Mutual of America Capital Management's AngioDynamics position peaked at $159K in Q3 2022.
- 149 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2022.
Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.